These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35973188)

  • 1. A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease.
    He K; Guo LL; Tang H; Peng X; Li J; Feng S; Bie C; Chen W; Li Y; Wang M; Tang S
    Am J Gastroenterol; 2022 Oct; 117(10):1621-1631. PubMed ID: 35973188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Dietary White Meat and Red Meat on NAFLD Progression by Modulating Gut Microbiota and Metabolites in Rats.
    Li J; Li Y; Feng S; He K; Guo L; Chen W; Wang M; Zhong L; Wu C; Peng X; Tang S
    Oxid Med Cell Longev; 2022; 2022():6908934. PubMed ID: 36035222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial.
    He Y; Chen X; Li Y; Liang Y; Hong T; Yang J; Cao Z; Mai H; Yao J; Zhang T; Wu K; Zou J; Feng D
    Am J Clin Nutr; 2024 Jul; 120(1):66-79. PubMed ID: 38795741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In nonalcoholic fatty liver disease, a diet of freshwater fish vs. freshwater fish plus red meat reduced liver fat.
    Mukherjee S
    Ann Intern Med; 2023 Feb; 176(2):JC20. PubMed ID: 36745890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
    Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
    Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
    J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Strains of
    Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation.
    Al-Awadi A; Grove J; Taylor M; Valdes A; Vijay A; Bawden S; Gowland P; Aithal G
    BMJ Open; 2021 Oct; 11(10):e045802. PubMed ID: 34620653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
    Zhong FW; Li GX; Zeng L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
    Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chin brick tea [Camellia sinensis (L.) Kuntze] on lipid metabolism and inflammation by modulating intestinal flora and bile acids in mice with non-alcoholic fatty liver disease.
    Jin C; Zhou T; Duan Z; Deng Y; Zhang X; Xiao C; He J; He G; Zhou Y; Li S
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116950. PubMed ID: 37506781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
    Zhang Z; Chen X; Cui B
    Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Probiotics (MCP
    Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
    Gao X; Lin X; Xin Y; Zhu X; Li X; Chen M; Huang Z; Guo H
    J Nutr Biochem; 2023 Jul; 117():109347. PubMed ID: 37031879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
    J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
    Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
    Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition.
    Zou J; Xiang Q; Tan D; Shi L; Liu X; Wu Y; Yu R
    Biomed Pharmacother; 2023 Jan; 157():114002. PubMed ID: 36410120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.